» Articles » PMID: 38201632

The National Burden of Colorectal Cancer in the United States from 1990 to 2019

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2024 Jan 11
PMID 38201632
Authors
Affiliations
Soon will be listed here.
Abstract

CRC accounts for approximately a tenth of all cancer cases and deaths in the US. Due to large differences in demographics among the different states, we aim to determine trends in the CRC epidemiology and across different states, age groups, and genders. CRC rates, age-adjusted to the standard US population, were obtained from the GBD 2019 database. Time trends were estimated as annual percentage change (APC). A pairwise comparison was conducted between age- and gender-specific trends using the tests of parallelism and coincidence. Age-specific trends were also assessed in two age subgroups: younger adults aged 15-49 years and older adults aged 50-74 years. We also analyzed the prevalence, incidence, mortality, and DALYs in the US between 1990 and 2019. A total of 5.53 million patients were diagnosed with CRC in the US between 1990 and 2019. Overall, CRC incidence rates have significantly increased in younger adults (11.1 per 100,000 persons) and decreased in older adults (136.8 per 100,000 persons) (AAPC = 1.2 vs. -0.6; AAPC difference = 1.8, < 0.001). Age-specific trends were neither identical ( < 0.001) nor parallel ( < 0.001), suggesting that CRC incidence rates are different and increasing at a greater rate in younger adults compared to older adults. However, for both men and women (49.4 and 35.2 per 100,000 persons), incidence rates have decreased over the past three decades at the same rate (AAPC = -0.5 vs. -0.5; AAPC difference = 0, = 0.1). Geographically, the southern states had the highest mortality rates with Mississippi having the highest rate of 20.1 cases per 100,000 population in 2019. Massachusetts, New York, and the District of Colombia had the greatest decreases in mortality over the study period (-42.1%, -41.4%, and -40.9%). Decreased mortality was found in all states except Mississippi, where the mortality of CRC increased over the study period (+1.5%). This research provides crucial insights for policymakers to tailor resource allocation, emphasizing the dynamic nature of CRC burden across states and age groups, ultimately informing targeted strategies for prevention and intervention.

Citing Articles

Chronobiology of Cancers in the Liver and Gut.

Ferrell J Cancers (Basel). 2024; 16(17).

PMID: 39272783 PMC: 11394324. DOI: 10.3390/cancers16172925.


Inflammatory bowel disease burden in the Middle East and North Africa Region: a comprehensive analysis of incidence, prevalence, and mortality from 1990-2019.

Alsakarneh S, Ahmed M, Jaber F, Abuassi M, Mourad F, Francis F Ann Gastroenterol. 2024; 37(5):527-535.

PMID: 39238799 PMC: 11372542. DOI: 10.20524/aog.2024.0909.


A CLRN3-Based CD8 T-Related Gene Signature Predicts Prognosis and Immunotherapy Response in Colorectal Cancer.

Gong Z, Huang X, Cao Q, Wu Y, Zhang Q Biomolecules. 2024; 14(8).

PMID: 39199281 PMC: 11352867. DOI: 10.3390/biom14080891.


Disparities in Colorectal Cancer Incidence in the United States, 2000-2019.

Alsakarneh S, Kilani Y, Jaber F, Ahmed M, Rawabdeh L, Bilal M Gastro Hep Adv. 2024; 3(4):562-564.

PMID: 39131713 PMC: 11308021. DOI: 10.1016/j.gastha.2024.01.004.


Increased Risk of Breakthrough SARS-CoV-2 Infections in Patients with Colorectal Cancer: A Population-Based Propensity-Matched Analysis.

Alsakarneh S, Jaber F, Qasim H, Massad A, Alzghoul H, Abboud Y J Clin Med. 2024; 13(9).

PMID: 38731022 PMC: 11084503. DOI: 10.3390/jcm13092495.

References
1.
Liang P, Chen T, Giovannucci E . Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer. 2009; 124(10):2406-15. DOI: 10.1002/ijc.24191. View

2.
Kelly H, Goldberg R . Systemic therapy for metastatic colorectal cancer: current options, current evidence. J Clin Oncol. 2005; 23(20):4553-60. DOI: 10.1200/JCO.2005.17.749. View

3.
Nejadghaderi S, Roshani S, Mohammadi E, Yoosefi M, Rezaei N, Esfahani Z . The global, regional, and national burden and quality of care index (QCI) of colorectal cancer; a global burden of disease systematic analysis 1990-2019. PLoS One. 2022; 17(4):e0263403. PMC: 9022854. DOI: 10.1371/journal.pone.0263403. View

4.
Doubeni C, Laiyemo A, Major J, Schootman M, Lian M, Park Y . Socioeconomic status and the risk of colorectal cancer: an analysis of more than a half million adults in the National Institutes of Health-AARP Diet and Health Study. Cancer. 2012; 118(14):3636-44. PMC: 3422782. DOI: 10.1002/cncr.26677. View

5.
Sharma R . A comparative examination of colorectal cancer burden in European Union, 1990-2019: Estimates from Global Burden of Disease 2019 Study. Int J Clin Oncol. 2022; 27(8):1309-1320. DOI: 10.1007/s10147-022-02182-0. View